Breanne began her legal career at a small firm in Los Angeles representing Plaintiffs in employment discrimination matters. After excelling at various firms, she landed at a large, nationally-recognized Plaintiff’s firm where she continued advocating for various women’s and childrens ‘health issues until January 2018, when she set off to establish her own firm, in Burlingame, California.

About Our firm

Breanne has spent her entire career representing women injured by various medical devices and cosmetics, most notably transvaginal mesh devices, the Essure device (a permanent sterilization device for women), and talcum powder products. She served at the behest of the Executive Committee in the transvaginal mesh litigations for eight years and was part of the trial team in Barba v. Boston Scientific Corp., (CA 11C-08-050-MMJ, Superior Court of Delaware (Wilmington) which obtained the largest jury verdict against a transvaginal mesh defendant to date.

The filing of these cases led to the leading mesh manufacturer to take its most dangerous products off the mark in the United States, as well as sweeping regulatory actions by the U.S. Federal Drug Administration, including reclassification of mesh devices from Class II to Class III devices and federally mandated clinical trials.

Breanne continues to represent women injured by these products all over the country. Because of her extensive experience and expertise, she is sought after by other Plaintiffs firms to teach their own attorneys about transvaginal mesh and the injuries it causes and to assist in working their own cases up for trial.

At her former firm, Breanne helped to establish the Essure JCCP (No. 4887) in Alameda County, Essure Product Cases. Breanne wrote the winning brief in Bayer Corporation, et al., v. Jacqueline Alexander, et al., Court of Appeals for the Ninth Circuit, Case No. CV-16-6822-MWF (MRW), 2017, which allowed the case to proceed in California State Court.

Qualified Legal Attorneys
Over 20 Years of Experience
Our Awards and Certificates

In her work for Lead Counsel of the Johnson & Johnson Talcum Powder litigation, she worked extensively with leading urogynecologic oncologists to develop the Plaintiff’s liability case and demonstrate the causal link between talc and ovarian cancer. This work was recently the subject of an extensive opinion by MDL Judge Freda Wolfson on April 27, 2020, which found that Plaintiff’s experts’ opinions used reliable methodology and substantially supported by science. Less than three weeks later, Johnson & Johnson announced it would discontinue approximately 100 products containing talcum powder in North America. In August 2022, Johnson & Johnson announced it would stop selling talc-based powder worldwide in 2023. Epidemiological studies have shown that between 2,200-5,000 of new ovarian cancer cases were caused by talcum powder use by women – cases that will never occur in future generations of women and girls.

Breanne’s talents and expertise have been recognized by numerous groups and professional organizations. She has been recognized as a Northern California Super Lawyer Rising Star each year as the founder of BGAN Law, 2018-2020. She is frequently called upon to speak at conferences and continuing education events. Notably, Breanne was tapped to speak at the 40th Annual Meeting of the International Urogynecologic Association in Nice, France, on the controversial topic of transvaginal mesh litigation. An interactive workshop, the presentation represented an important first – bringing the doctors using transvaginal mesh products all over the world an inside look at the litigation and evidence used at various mesh trials and facilitating a productive and novel conversation with attorneys and healthcare providers on the issues surrounding transvaginal mesh.